# Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum

> **NCT05325099** · PHASE1,PHASE2 · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Acute Kidney Disease

## Interventions

- **DRUG:** Azacitidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05325099
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-18
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05325099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05325099, "Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05325099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*